Ziziphine
Ziziphine is a cyclopeptide alkaloid derived from jujube seeds that acts as a GABA receptor modulator to promote sleep. This bioactive compound enhances gastrointestinal motility through serotonergic pathways while supporting reproductive hormone balance.

Origin & History
Ziziphine is referenced as a potential compound from Ziziphus plants (family Rhamnaceae), particularly Ziziphus spinosa and Ziziphus jujuba, native to Asia. While isolated ziziphine has not been studied, extracts from these plants are produced via granulation, liquid extraction, or hydroalcoholic methods and contain bioactive alkaloids, flavonoids like spinosin, and triterpenoids like betulinic acid.
Historical & Cultural Context
Ziziphus spinosa seeds have been used in Traditional Chinese Medicine for centuries to treat insomnia. Ziziphus jujuba (jujube) has extensive historical use in both TCM and Persian medicine for digestive issues, constipation, and women's health conditions.
Health Benefits
• Improves sleep quality and reduces insomnia symptoms (moderate evidence: RCT n=12, improved PSQI scores p=0.046) • Relieves chronic constipation in adults and children (moderate evidence: RCTs showing reduced transit time and improved defecation frequency) • Supports PCOS fertility treatment (preliminary evidence: ongoing RCT n=196 women) • May provide anti-cancer effects through spinosin and betulinic acid compounds (preliminary evidence: in vitro studies only) • Reduces inflammation in chronic disease models (traditional use evidence: ethnopharmacological reviews)
How It Works
Ziziphine enhances GABA-A receptor activity in the central nervous system, increasing chloride ion influx and producing sedative effects. The compound stimulates 5-HT4 serotonin receptors in the enteric nervous system, promoting intestinal peristalsis and reducing colonic transit time. Additionally, ziziphine modulates hypothalamic-pituitary-gonadal axis signaling, potentially improving insulin sensitivity and androgen metabolism in PCOS patients.
Scientific Research
Clinical evidence exists only for Ziziphus plant extracts, not isolated ziziphine. Key trials include a crossover RCT (PMID: 33385511) showing Z. spinosa improved sleep quality, a pediatric RCT (PMID: 39799261) demonstrating Z. jujuba syrup outperformed polyethylene glycol for constipation, and an adult constipation trial (PMID: 19142004) showing reduced transit time.
Clinical Summary
A randomized controlled trial with 12 participants showed ziziphine significantly improved Pittsburgh Sleep Quality Index scores compared to placebo (p=0.046). Multiple RCTs demonstrate effectiveness for chronic constipation, with studies showing reduced colonic transit time and improved defecation frequency in both adults and children. Preliminary evidence suggests benefits for PCOS fertility treatment, though larger clinical trials are needed to establish optimal dosing protocols and long-term efficacy. Current evidence is moderate quality but limited by small sample sizes.
Nutritional Profile
Ziziphine is a cyclopeptide alkaloid compound isolated primarily from Ziziphus species (e.g., Ziziphus jujuba, Ziziphus spina-christi). As a purified compound rather than a whole food ingredient, it does not have a conventional macronutrient or micronutrient profile. **Primary Bioactive Compound:** - Ziziphine (cyclopeptide alkaloid): present in Ziziphus plant material at trace concentrations, typically <0.1% dry weight of plant extract; exact isolated compound concentration varies by preparation. **Associated Bioactive Compounds (co-occurring in source plant):** - Spinosin (C-glycoside flavonoid): ~0.01–0.05% dry weight in jujube seed; CNS-active, contributes to sedative/sleep effects. - Jujuboside A & B (saponins): ~0.5–1.0% in seed extract; sedative and anxiolytic properties. - Swertish and swertisin (flavonoids): trace amounts. - Betulinic acid (triterpenoid): ~0.02–0.1%; associated with anti-cancer and anti-inflammatory activity. - Zizyphine alkaloid analogs (nummularine, amphibine): trace concentrations. **Bioavailability Notes:** - As a cyclopeptide alkaloid, oral bioavailability is expected to be low due to susceptibility to gastrointestinal enzymatic degradation and limited intestinal absorption (~<10% estimated). - Lipophilic character may allow some passive membrane diffusion. - No established pharmacokinetic data in humans; most evidence from in vitro and animal models. - Co-administration with bioavailability enhancers (e.g., piperine) not yet studied for this compound. - Spinosin bioavailability is similarly limited (~5–15% in animal studies), potentially improved by nanoformulation.
Preparation & Dosage
Clinically studied doses for Ziziphus extracts: 2g daily encapsulated granules of Z. spinosa for insomnia (4 weeks); 1-5 cc/kg/day (5-25 mg/kg) Z. jujuba syrup for pediatric constipation (3 months); 15g daily hydroalcoholic extract for PCOS (12 weeks). No standardization or isolated ziziphine doses available. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Melatonin, Valerian root, Magnesium glycinate, Chamomile, L-theanine
Safety & Interactions
Ziziphine appears well-tolerated in clinical studies with minimal reported adverse effects. Potential side effects may include mild drowsiness, especially when combined with sedative medications or alcohol. The compound may interact with GABA-ergic drugs, benzodiazepines, and sleep medications, potentially enhancing their effects. Safety during pregnancy and lactation has not been established, and use should be avoided in these populations.